Xu, Mingxing <br/><br/>
Antiviral therapy predicts the outcomes following resection of hepatocellular carcinoma in patients negative for HBV DNA: a propensity score matching analysis.  [electronic resource] 

 -  World journal of surgical oncology  Mar 2019 
 - 45 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>1477-7819 
<br/><br/><label>Standard No.: </label>10.1186/s12957-019-1577-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiviral Agents--pharmacology<br/>Carcinoma, Hepatocellular--blood<br/>DNA, Viral--isolation & purification<br/>Disease-Free Survival<br/>Female<br/>Hepatectomy<br/>Hepatitis B virus--drug effects<br/>Humans<br/>Liver--pathology<br/>Liver Neoplasms--blood<br/>Male<br/>Middle Aged<br/>Postoperative Period<br/>Prognosis<br/>Propensity Score<br/>Retrospective Studies<br/>Risk Factors<br/>Survival Rate<br/>Virus Activation--drug effects